ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,146.86
-0.21%
Dow Jones
38,589.16
-0.15%
Gold vs US Dollar
2,333.015
0.00%
Brent Oil
82.275
0.00%
Bitcoin
66,498.66
0.46%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC
  6. Sorrento Therapeutics Inc (CE) (SRNEQ)

  7. Sorrento Therapeutics Inc (CE) (SRNEQ) News

Sorrento Therapeutics (CE) (SRNEQ)

Sorrento Therapeutics Inc (CE)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:SRNEQ
DateTimeSourceHeadlineSymbolCompany
07/11/202321:34Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
05/10/202322:26Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
05/10/202322:22Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
05/10/202322:16Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
26/09/202321:54Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
26/09/202321:49Edgar (US Regulatory)Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]USOTC:SRNEQSorrento Therapeutics Inc (CE)
25/09/202321:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesUSOTC:SRNEQSorrento Therapeutics Inc (CE)
21/08/202316:20Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
10/08/202321:14Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
18/07/202322:23Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementUSOTC:SRNEQSorrento Therapeutics Inc (CE)
08/07/202302:49Edgar (US Regulatory)Form 8-K - Current reportUSOTC:SRNEQSorrento Therapeutics Inc (CE)
21/06/202322:25Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/06/202322:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
15/06/202314:44Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
19/05/202311:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
15/05/202320:18Edgar (US Regulatory)Quarterly Report (10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
15/05/202317:04Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
12/05/202322:29Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)USOTC:SRNEQSorrento Therapeutics Inc (CE)
09/05/202311:03Edgar (US Regulatory)Notification That Quarterly Report Will Be Submitted Late (nt 10-q)USOTC:SRNEQSorrento Therapeutics Inc (CE)
03/05/202311:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/04/202322:28Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/04/202317:09Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
12/04/202313:51Edgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)USOTC:SRNEQSorrento Therapeutics Inc (CE)
10/04/202322:23Edgar (US Regulatory)Amended Current Report Filing (8-k/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
10/04/202320:16Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
31/03/202311:17Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/03/202323:54Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)USOTC:SRNEQSorrento Therapeutics Inc (CE)
20/03/202310:02Edgar (US Regulatory)Current Report Filing (8-k)USOTC:SRNEQSorrento Therapeutics Inc (CE)
10/03/202316:22Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
08/03/202319:20Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)USOTC:SRNEQSorrento Therapeutics Inc (CE)
 Showing the most relevant articles for your search:USOTC:SRNEQ

Your Recent History

LSE
LLOY
Lloyds Banking
LSE
PANR
Pantheon Resources
LSE
GOLD
LSE
VAST
Vast Resources
LSE
BIRD
Blackbird
LSE
ENET
Ethernity Networks
LSE
GKP
Gulf Keystone Petroleum
LSE
ARCM
Arc Minerals
LSE
NEXN
Nexxen
LSE
PHNX
Phoenix
LSE
SRSP
Sirius Petroleum
LSE
NSCI
Netscientific
LSE
EEE
Empire Metals
LSE
SBTX
Skinbiotherapeutics
LSE
FUM
Futura Medical
LSE
GMET
Golden Metal Resources
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved